8-K - Crinetics Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 6, 2026, Crinetics Pharmaceuticals, Inc. (“Crinetics” or the “Company”) entered into an underwriting agreement (the “Underwriting Agree

Other Event

$45.95$43.42$330.2M$379.8M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated January 6, 2026, by and among Crinetics Pharmaceutica

Exhibits Only

Source Document

Exhibits (5)

1.1

EX-1.1

5.1

EX-5.1

8-K

99.1

EX-99.1

99.2

EX-99.2